分子光譜市場-技術【核磁共振光譜（傅立葉變換NMR、固態NMR）、紫外-可見（雙光束紫外-可見、單光束紫外-可見）、紅外線、近紅外線】、端-用戶，全球預測（ 2024 - 2032）

Molecular Spectroscopy Market - Technology [Nuclear Magnetic Resonance Spectroscopy (Fourier-transform NMR, Solid-state NMR), UV-Visible (Dual-beam UV-visible, Single-beam UV-visible), Infrared, Near-infrared], End-user, Global Forecast (2024 - 2032)

出版日期: 2024年04月02日 | 出版商:

Global Market Insights Inc. | 英文 270 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於分析技術的技術進步和創新，分子光譜市場規模預計 2024 年至 2032 年間複合年成長率為 6%。快速的進步使研究人員能夠在各個行業中進行更精確的分析。製藥和生物技術領域的藥物開發以及食品、飲料和環境監測的品質控制對分子成像的需求不斷成長。例如，2023 年 10 月，TrinamiX GmbH 推出了由新的 Snapdragon(R) 8 Gen 3 參考設計提供支援的消費光譜解決方案。

研究人員的意識和接受度的提高以及新興經濟體製藥和生物技術行業的擴張正在增加政府對研發活動的財政支持。對醫療基礎設施的投資增加以及大學和研究機構對分子光譜儀器不斷成長的需求也將推動市場成長。

分子光譜產業分為技術、最終用戶和地區。

基於技術，由於紅外光譜領域在各行業的多功能性，到 2032 年，其市場規模將出現顯著的複合年成長率。紅外光譜提供詳細的分子分析和無損性質，使其在各個行業中至關重要。手持設備等技術的進步也促進了現場應用的使用。人們對製造流程分析技術 (PAT) 的興趣日益濃厚，加上品質控制和保證的加強，將促進該細分市場的成長。

就最終用戶而言，由於藥物發現和開發程序越來越依賴先進的分析技術，CRO 領域的分子光譜市場預計將在 2024 年至 2032 年期間產生顯著成長。 CRO 透過利用分子光譜技術進行快速且準確的診斷以及提高研究效率和縮短週轉時間，為製藥、生物技術和學術機構提供外包研究服務。

由於製藥和生物技術產業的崛起，亞太地區分子光譜產業將在 2032 年實現持續成長。醫療保健基礎設施投資的增加、政府研發措施的激增以及藥品製造的擴張正在推動當地醫藥和生技產業的發展。太空方法也被用於食品和飲料（F&B）領域，用於品質控制、環境監測和科學研究，進一步推動區域市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 增加製藥公司的應用和採用
  - 專注於新藥研發的研發活動不斷增加
  - 分子光譜領域的技術進步
- 產業陷阱與挑戰
  - 分子光譜成本高
  - 專業知識和培訓的要求
成長潛力分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按技術分類，2021 - 2032 年

主要趨勢
核磁共振 (NMR) 光譜
- 傅立葉變換核磁共振波譜 (FTS)
- 固態核磁共振波譜 (SSNMR)
- 連續波 (CW) NMR 波譜
紫外可見光譜
- 雙光束紫外可見光譜
- 單光束紫外可見光譜
- 基於陣列的紫外-可見光譜
紅外線 (IR) 光譜
- 中波紅外光譜
- 短波紅外光譜
- 遠波紅外光譜
近紅外光譜
- 傅立葉變換
- 掃描
- 過濾器或 AOTF
拉曼光譜
- 透過抽樣技術
  - 表面增強拉曼散射
  - 尖端增強拉曼散射
  - 其他採樣技術
- 按類型
  - 顯微拉曼光譜
  - 基於探針的拉曼光譜
  - 傅立葉變換拉曼光譜
其他技術

第 6 章：市場估計與預測：按最終用戶分類，2021 - 2032 年

主要趨勢
製藥和生物技術公司
學術及研究機構
合約研究組織
其他最終用戶

第 7 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 8 章：公司簡介

Agilent Technologies Inc.
Bruker Corporation
Danaher Corporation
Horiba Ltd.
Jasco Inc.
Jeol Ltd.
Merck KGaA
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
VIAVI Solutions Inc.

簡介目錄

Product Code: 8822

Molecular spectroscopy market size is anticipated to register 6% CAGR between 2024 and 2032, owing to technological advancements and innovations in analytical techniques. Rapid advancements have enabled researchers to conduct more precise analysis in various industries. There is growing demand for molecular imaging in pharmaceutical and biotech sectors for drug development, as well as in quality control across food, beverage, and environmental monitoring. To illustrate, in October 2023, TrinamiX GmbH launched its consumer spectroscopy solution powered by the new Snapdragon(R) 8 Gen 3 reference design.

Surging awareness and acceptance among researchers and the expansion of pharmaceutical and biotech industries in emerging economies is increasing the government financial support for R&D activities. Higher investments in healthcare infrastructure, and the rising demand for molecular spectroscopy instruments from universities and research institutes will also drive the market growth.

The molecular spectroscopy industry is classified into technology, end-user and region.

Based on technology, the market size from the infrared spectroscopy segment will witness significant CAGR through 2032, due to its versatility across various industries. Infrared spectroscopy offers detailed molecular analysis and non-destructive nature, making it crucial in various industries. Advances in technology like handheld devices are also boosting usage in field applications. Growing interest in process analysis technology (PAT) in manufacturing along with increased quality control and assurance will add to the segment growth.

With respect to end-user, the molecular spectroscopy market from the CROs segment is slated to generate notable gains during 2024-2032, due to increasing dependence on advanced analytical techniques for drug discovery and development procedure. CROs offer outsourced research services to pharmaceutical, biotech, and academic institutions by utilizing molecular spectroscopy technology for rapid and accurate diagnostics as well as enhancing research efficiency and reducing turnaround time.

Asia Pacific molecular spectroscopy industry will record sustained growth rate through 2032, attributed to rising pharmaceutical and biotechnology sector. Increased investments in healthcare infrastructure, surge in government initiatives for R&D, and expansion of pharmaceutical manufacturing are boosting the local medicine and biotech sector. Spatial methods are also being used in food & beverage (F&B) sector for quality control, environmental monitoring, and scientific research, further driving the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing application and adoption in pharmaceutical companies
  - 3.2.1.2 Rising research and development activities focusing on the creation of novel drugs
  - 3.2.1.3 Technological advancement in the field of molecular spectroscopy
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of molecular spectroscopy
  - 3.2.2.2 Requirement of specialized expertise and training
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Nuclear magnetic resonance (NMR) spectroscopy
- 5.2.1 Fourier-transform NMR spectroscopy (FTS)
- 5.2.2 Solid-state NMR spectroscopy (SSNMR)
- 5.2.3 Continuous-wave (CW) NMR spectroscopy
5.3 UV-visible spectroscopy
- 5.3.1 Dual-beam UV-visible spectroscopy
- 5.3.2 Single-beam UV-visible spectroscopy
- 5.3.3 Array-based UV-visible spectroscopy
5.4 Infrared (IR) spectroscopy
- 5.4.1 Mid-wave infrared spectroscopy
- 5.4.2 Short-wave infrared spectroscopy
- 5.4.3 Far-wave infrared spectroscopy
5.5 Near-infrared spectroscopy
- 5.5.1 Fourier-transform
- 5.5.2 Scanning
- 5.5.3 Filter or AOTF
5.6 Raman spectroscopy
- 5.6.1 By sampling technique
  - 5.6.1.1 Surface-enhanced Raman scattering
  - 5.6.1.2 Tip-enhanced Raman scattering
  - 5.6.1.3 Other sampling techniques
- 5.6.2 By type
  - 5.6.2.1 Micro-raman spectroscopy
  - 5.6.2.2 Probe-based raman spectroscopy
  - 5.6.2.3 Fourier tranform-raman spectroscopy
5.7 Other technologies

Chapter 6 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Pharmaceutical & biotechnology companies
6.3 Academic and research institutes
6.4 CROs
6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East and Africa